Gregory Ramirez2 said:Does anyone have a rough idea about the medical success rates for this kind of tumor? Like, what are the roughly min/max timelines we're looking at? I mean, how long does someone typically live after surgery and getting a diagnosis like this?
In your experience—or just from what you’ve heard—what’s the reality of those timeframes? I’m not looking for exact numbers, just a general ballpark so we know how much time there is to act, get treatment, or... you know, say our goodbyes...
Also, does anyone know if those Dren-Trogrlić Žepče herbal blends from Canada actually do anything for brain tumors (alongside whatever the doctors prescribed, obviously)?
So, the patient is a woman, 55 years old, and she just went through her third brain surgery.
The first two scans showed it wasn't malignant, but this latest one confirmed it's an anaplastic Meningioma Grade III according to the WHO.
The report also mentions: "Bone structure and brain tissue infiltration identified, IM 33/3 HPF."
If anyone knows of any other solutions or help—maybe from a different herbalist or some other alternative route—please, please shoot me a PM.
I would be incredibly grateful for any info at all. This is for a colleague of mine—she's such a wonderful, kindhearted woman and a great mom.
Everything you need to know has pretty much already been laid out right here:
The research presented here regarding meningiomas is a heavy lift, but it’s essential reading if you want to understand the actual mechanics behind tumor progression. We aren't just looking at surface-level statistics; we are digging into the cellular architecture that dictates how these things behave. It’s one thing to read a general summary, but it's an entirely different beast when you start parsing through the specific molecular pathways that drive malignancy. When you look at Grade III cases, the complexity spikes significantly. You can't just apply a blanket logic to everything; the biological reality is much more volatile. It’s like trying to predict the path of a storm based solely on the wind speed—you have to account for the pressure changes and the underlying temperature shifts too. In this case, those "shifts" are the genetic mutations and protein expressions that turn a manageable growth into something aggressive. If you aren't paying attention to these granular details, you're essentially flying blind.
Look, here’s the deal: we're dealing with a rare brain tumor that typically starts out as benign before mutating into a malignant, anaplastic type—which is exactly what happened in your case. It also has a nasty tendency to recur.
We’re dealing with a rare disease here—the kind that hits fewer than five people out of every 10,000. Just like most other orphan diseases, it suffers from a massive lack of fundamental research and a glaring shortage of effective treatments. For the most part, medical options are stuck in a loop of surgical removal and radiation. There isn't any chemotherapy out there that actually works for this. From a purely statistical standpoint, the prognosis is grim. This study published in the journal examines how certain types of meningiomas respond to radiation therapy. It’s a deep dive into the specifics of Grade III tumors—those aggressive ones that don't play by the rules. Essentially, the researchers looked at how we can better predict which patients are going to see actual progress after treatment and which ones might need a different approach entirely. It’s the kind of data that shifts the needle from "let's try this" to "we know this works."
Look, when people start obsessively staring at statistics, they have this annoying habit of trying to force every single individual case into a neat little average. It’s a fallacy. No one can predict an outcome for a specific person with absolute certainty because life isn't a math equation—it's a chaotic mess of infinite variables all pulling at once. Statistics work by creating a bell curve—you've got your left tail, your center, and your right tail. But let's get one thing straight: nobody can tell you exactly where any one person is going to land on that curve.
My best advice, coming from someone who has stared down an incredibly aggressive and hopeless diagnosis, is this: don't let it consume you. Every single one of us has an expiration date written somewhere, and frankly, most of us don't know when it is—which is exactly how it should be. People who think they "know" their timeline usually just spend their remaining days paralyzed by that knowledge, which only serves to strip away their quality of life. Patients and their families need to grab every possible second they can. Focus on the mundane, everyday stuff and those tiny, simple pleasures; just soak up high-quality time for as long as it lasts. You have to live day by day and deal with things as they land on your plate. I’ve seen plenty of people take such an assertive, defiant approach to life that they actually defy the odds, sometimes even sliding right back into remission.
When my mother first got her diagnosis, a few of her close friends dropped everything to come by one last time just to say goodbye. They left in absolute tears. It’s wild, though—they all passed away unexpectedly shortly after her. No one saw any of it coming.
Life is a shot in the arm, and you’ve got to grab it by the throat and fight for every inch while you're still standing—whatever comes, comes. There aren't any guarantees in this life, nothing at all, except for the fact that we’re all just passing through. All we really get to do is choose how we decide to face that inevitable fade-out.
